Antibiotics are the wonder discoveries to combat microbes. For decades, multiple varieties of antibiotics have been used for therapeutic purposes in hospital settings and communities throughout the world. Unfortunately, bacteria have become resistant to commonly prescribed antibiotics. This review aims to explore the development, challenges, and the current state of antibiotic resistance available literature in Malaysia. Recently published data from Pubmed, Scopus, Google scholar's and other internet source publication on the antibiotic resistance of gram-negative bacteria were further reviewed and analysed in this study. This review reiterates the antibiotic resistance among the gram-negative bacteria is increasing and they are becoming resistant to nearly all groups of antibiotics. The antibiotic treatments are minimal and hard to treat in multi-drug resistance bacterial infection, resulting in morbidity and mortality. The prevalence rate of antibiotic resistance from the literature suggests that educating patients and the public is essential to prevent and control the spread of antibiotic resistance. In particular, there is an urgent need for a surveillance system of regular monitoring on the microbiomes, the discovery of novel antibiotics and therapeutic application of antibiotics are mandatory.
INTRODUCTION
Antimicrobial resistance creates a significant health problem worldwide by its various factors, especially in hospital settings. The primary factors include the exposures to cross infection and broadspectrum antimicrobials. Understanding the extent and type of antimicrobial use might help in developing an awareness of antibiotic resistance. Becoming resistant to multiple antibiotics is a serious threat of gramnegative bacteria through out the world. These resistant bacteria most of the times prolong the treatment procedures and also transfer its' genetic material to other bacteria to transform the bacteria into a drug-resistant strain (World Health Organization, 2017, 27 February). The occurrences of multidrugresistant (MDR) pathogens are contineously increasing although many different ways are employed to combat the antibiotic resistance of the pathogens (Laxminarayan et al., 2013) . Millions of lives are being saved by transforming antibiotics into medicine while prevalence of antibiotic resistance is reported worldwide (Golkar, Bagasra, & Pace, 2014) . Antibiotics play essential roles in achieving significant advances in medicine and surgery through saving millions of patients' lives. Many decades after the first patient was treated with antibiotics yet bacterial infections are a major threat to health managements (Spellberg & Gilbert, 2014) . Inappropriate use of antibiotic therapy associated with disease can lead to the development of drug-resistant strains (Deris, 2015) . Volume 45 | Journal of International Pharmaceutical Research
The antibiotic resistance crisis is due to the overuse and misuse, along with incapability to develop new drug by the pharmaceutical companies. The Centres for Disease Control and Prevention (CDC) has classified some bacteria as presenting urgent, dangerous, and concerning threats. Antibiotic resistance gram-negative bacteria including extended spectrum β-lactamases (ESBLs) and multidrugresistant have emerged and spread throughout Malaysia.
METHODS

Literature search, definition and selection strategy
In this article, it was reviewed and summarized the current critical knowledge on the epidemiolocal as well as molecular characterization of antibiotic resistance in Malaysia. The National Surveillance of Antibiotic Resistance (NSAR) report by the Ministry of Health, Malaysia have revealed data until 2017 from 39 hospital-based microbiology laboratories which included thirty-seven microbiology laboratories of government hospitals, and 2 hospital based university. The published articles in Pubmed, Scopus, Google scholar's and other recent internet source publication on the antibiotic resistance of gramnegative bacteria were further reviewed and included in this study.
Result and Discussion
The most critical group of gram-negative bacteria which causes diseases and become resistant to multiple antibiotics was highlighted. The multidrug resistant bacteria such as Acinetobacter, Pseudomonas and various Enterobacteriaceae including Klebsiella, and E. coli can cause severe and often deadly infections those are frequently reported in the hospitals and clinics. However, many studies reported that gram-negative bacteria showed multiple-antibiotic resistance due to misuse of antibiotics, longer duration of prior antimicrobial therapy and a higher number of antimicrobial applications to control infections. Highest and medium priority categories of bacteria those cause bloodstream infections and pneumonia was reviewed under current scope. This study would give a clear view on the urgency (critical, high and medium priority) of new antibiotics development. It was also presented the most dominant bacteria causing various types of diseases throughout the world as well as in Malaysia.
Acinetobacter
Acinetobacter is a complex genus with the existence of multiple species. The species commonly cause nosocomial infections, pneumonia, catheterassociated bacteremia, soft tissue and urinary tract infections (Wong et al., 2017) . Acinetobacter spp. described as natural transformable bacteria and can become resistant to many different classes of antibiotics (Perez et al., 2007 (Lean et al., 2014) . Moreover, a molecular study on 40 isolates of Acinetobacter spp.were resistant to ciprofloxacin (55%), imipenem (67.5%), amikacin (50%), gentamicin (52.5%), ampicillin (75%), ceftazidime (60%), meropenem (92.5%), piperacillin (77.5%), cefoperazone (60%) and tazobactam/piperacillin (67.5%) respectively. Meropenem showed the maximum resistance (92.5%) followed by piperacillin (77.5%) and ampicillin (75%). In addition, 5% Acinetobacter strains were resistant to one antibiotic, 10% strains to two antibiotics, and 85% strains to three or more antibiotics (Nazmul, Jamal, & Fazlul, 2012 The presence of multidrug-resistance (MDR) in Acinetobacter baumannii strains was observed in a tertiary-care center, Subang Jaya, Selangor, Malaysia by Jayakayatri in 2016. These studies revealed that the strains of Acinetobacter baumannii were resistance to 11 types of antimicrobials (polymyxin B, ampicillin/sulbactam, ceftazidime, meropenem, imipenem, amikacin, gentamicin, ciprofloxacin, levofloxacin, trimethoprim/sulfamethoxazole, and tigecycline). A total number of 53% strains were classified as multidrug-resistance (resistant to 4 or more antibiotics) ( 
Pseudomonas aeruginosa
Pseudomonas aeruginosa commonly caused different types of disease including communityacquired and nosocomial-acquired pneumonia. Over the years, the development of Pseudomonas aeruginosa resistance is increasing globally due to the overuse of antibiotics (Yayan, Ghebremedhin, & Rasche, 2015) . The resistance of P. aeruginosa occurs after 3-4 days of the initiation of treatment (Juayang et al., 2017) . The most severe nosocomial infection correlates with increased resistance to antibiotics with high morbidity and mortality (Sonmezer et al., 2016 Pseudomonas aeruginosa, the common pathogen causes nosocomial infections. In 2009, a molecular characterization was determined for 48 clinical isolates of P. aeruginosa from 6 public hospitals in Malaysia. The obtained data was analyzed by antimicrobial susceptibility test and DNA fingerprinting techniques. In these study P. aeruginosa isolates were resistant to tetracycline (73%), chloramphenicol (60%), cefotaxime (40%), ceftriaxone (31%), cefoperazone (29%), ticarcillin (25%), piperacillin (23%), and imipenem (21%). Less than 20% of P. aeruginosa were sensitive to ceftazidime, gentamicin, cefepime, ciprofloxacin, amikacin, piperacillin-tazobactam, and aztreonam. Moreover, 33 strains of P. aeruginosa (68.75 %) were multidrug resistant, and aztreonam was the most effective antibiotic (Lim et al., 2009 ). In a similar study, ninety (90) randomly selected non-replicate imipenem-resistant P. aeruginosa isolates were collected from UMMC, a university teaching hospital at Kuala Lumpur, Malaysia. All these clinical specimens were from nonrepetitive patients (57 females and 33 males). These study reported that antibiotic resistance profiles of P. aeruginosa isolate by using disk-diffusion tests. Ceftazidime 63% showed the highest resistant followed by amikacin 62% and least resistant to netilmicin 48% ( Among the different types of antibiotics, ceftazidime showed the higest resistance to The prevalence and antibiotic susceptibility of Gram-negative bacteria among infants admitted to the neonatal intensive care unit (NICU) in a tertiary teaching hospital in Malaysia described a total of 34 stool specimens obtained from infants of multidrugresistant k. pneumoniae unusually high resistance to polymyxins. In 2017, carbapenem-resistant of K. pneumoniae were resistant to tetracycline except two strains were intermediate, but only one strain was resistant to tigecycline in Malaysia. Among all the isolates, 47.06% strains were resistant to cephalosporin groups of antibiotics while all bacterial strains were sensitive to colistin and resistance to atleast one carbapenem (MIC = 4 ->32 μg/ml) antibiotic. Resistance to imipenem significantly associated with in-hospital mortality (P = 0.043). Two strains (K/1311-35 and K/1304-16) were resistant to imipenem (MIC = 4 -6 μg/ml) while sensitive to meropenem and ertapenem. One isolates of K. pneumoniae (K/1312-3) was sensitive to imipenem but resistant to meropenem and ertapenem (MIC = 6 -16 μg/ml). Again, three strains (17.65%) were resistant to aminoglycoside group of antibiotics (MIC = 24 ->256 μg/ml for gentamicin and tobramycin; MIC = 64 ->256 μg/ml for amikacin) while thirteen strains (76.47%) were resistant to all types of fluoroquinolones antibiotics (MIC = 8 ->32 μg/ml) (Low et al., 2017) .
Klebsiella pneumonia showed an increasing trend of antibiotic resistance over the years. National surveillance of antibiotic resistance reported that the resistant to carbapenems, namely imipenem (2.4%) and meropenem (2.8%) increased in 2015 compared to 2014 while cefuroxime showed higher resistance (28.4%) between 2013 and 2017. The least resistance was observed by imipenem 1.3% in 2013 past 5 years. Among all the recent studies on Klebsiella pneumonia have shown high resistance impact on the different antibiotics namely polymixins, ampicillin, extended-spectrum β-lactams, tetracycline and ampicillin/sulbactam whereas the least resistance to imipenem, meropenem, and amikacin.
Escherichia coli
Escherichia coli is the most common agent of various types of infection especially urinary tract infections (UTI), cholecystitis, cholangitis, diarrhoea, neonatal meningitis and pneumonia etc. The leading cause of bacteremia is due to Gram-negative Escherichia coli (Woodford, Turton, & Livermore, 2011) .
Noor Safina included a total of 721 cases to identify the resistance rates of gram-negative bacteria in 2015. Among all the patients 54% were male, and 46% were female. The 3 most common organisms isolated in the total population, Escherichia coli (41.6%) were the most prevalent organisms in both the prophylaxis (60.7%) and no prophylaxis (39.8%). Among the antibiotic resistance, E.coli showed a higher resistance to ampicillin (67.7%), cefuroxime (15.3%) and gentamicin (7.3%) respectively (Nor et al., 2015) .
In 2009, a study of Lim and his colleagues examined 47 nonrepeat E. coli isolates collected in 2004 from 47 different patients of 5 public hospitals located in different location of Malaysia. The participating hospitals were Kota Bharu Hospital (n = 10), Sultanah Aminah Hospital (n = 23), Kuala Lumpur Hospital (n = 10), Ipoh Hospital (n = 2), and Queen Elizabeth Hospital (n = 2). The data indicated a high prevalence of resistance to ampicillin (77%), piperacillin (64%), tetracycline (53%), trimethoprimsulfamethoxazole (43%), cefoperazone, kanamycin (30%), Nalidixic acid (28%), chloramphenicol (26%), ciprofloxacin (23%), gentamicin (21%), amoxicillinclavulanic acid (17%), ceftriaxone ceftazidime, and aztreonam 11% each, and amikacin 2% among all the E. coli isolates (Lim et al., 2009 ). Among them, 36 isolates (76.5%) were multidrug-resistant while cephalosporin resistant isolates were also resistant to ampicillin and 71% of them resistant to tetracycline. A large number of strains (72%) were resistant to aminoglycosides (Lim et al., 2009 ). Meanwhile, out of 76 gram-negative isolates of E. coli were resistant to amoxicillin/clavulanate (30.8%, n = 16), ceftriaxone (42.3%, n = 22), ceftazidime (28.8%, n = 15), cefoxitin (28.8%, n = 15), aztreonam (36.5%, n = 19), and polymyxin B (23.1%, n = 12) in hospitalized preterm infants. Among all the strains, 20 isolates of E. coli were resistant to more than three antibiotics categorized as multidrug-resistant (MDR) (Yap et al., 2016) . In another study in 2015, ampicillin showed the highest resistance to 67% compared to 68.9% in 2013. The least resistance by meropenem (0.5%) in 2015 had slightly increased to 0.9% in 2016 and reduced to 0.7% in 2017. In blood samples, cefuroxime and cefotaxime resistance rate rose to 25.4% and 25.9% in 2015 respectively. According to National surveillance of antibiotic resistance, Malaysia, the resistance rate of cephalosporins (cefuroxime 25.9% and cefotaxime 25.4%) has slightly increased in 2017 compared to 23.5% and 23.4% respectively in 2016. Even though imipenem (0.8%) and meropenem (0.7%) resistance rate were low in 2017, but an increasing trend of resistance was observed between 2010 and 2017 ( Figure 4 The antibiotic resistance trends among the Klebsiella spp., imipenem (80%) showed the highest increasing resistance trends followed by meropenem (71%), amikacin (53%), cefepime (40%), and amoxicillin/clavulanic acid (21%). In addition, gentamicin showed a decrease resistance trend by 19% followed by ciprofloxacin 1% between 2013 and 2017. In E. coli. isolates imipenem (167%) showed the highest increasing resistance trends followed by meropenem (133%), amikacin (88%), cefepime (32%), gentamicin (27%) and amoxicillin/clavulanic acid (21%) between 2013 and 2017. Among the most commonly prescribed antibiotics, ceftazidime (106%) showed the highest increasing resistance trends followed by cefoperazone/ sulbactam (18%), amikacin (14%), imipenem (13%), and gentamicin (11%) to Acinetobacter spp. between 2013 and 2017. In addition, polymyxin B showed a decrease resistance trend by 100%. In P. aeruginosa, amikacin showed an increasing resistance trend by 21% while cefepime was 8% since 2013 to 2017. Rest of the antibiotics (Meropenem 20%, ceftazidime 14%, and gentamicin 3%) showed a decrease resistance trend between 2013 and 2017 ( Figure 5 ). Volume 45 | Journal of International Pharmaceutical Research
Haemophilus influenzae
Haemophilus influenzae is an indigenous bacterium of the upper respiratory tract infection and also with Streptococcus pneumonia can cause respiratory tract infections (Seyama et al., 2016 
Neisseria gonorrhea
Gonorrhea is a sexually transmitted infection (STI) caused by variable strains Neisseria gonorrhoeae, and worldwide it is a worrisom matters in public health priority (Wi et al., 2017 
Conclusions
Among all the observed gram-negative bacteria over the years, an increasing trend of antibiotic resistance has revealed the prevalence rate of antibiotic resistance which leads to this study for a review. Thousands of bacterial isolates were examined from different place and locations all over Malaysia. Findings from this preliminary study indicated the prevalence rate of antibiotic-resistant bacteria in Peninsular Malaysia. The outcome of this study can be efficient on infection control measures, and antibiotic stewardship programs should be able to control the spread of the multidrug-resistant bacteria. This could be a proper guideline for appropriate antibiotics to use against gram-negative bacteria. The Most frequent antibiotic resistance profiles were observed by ampicillin, piperacillin, ceftazidime, and tetracycline, etc. regardless in Malaysia. The presence of multidrug resistant bacteria is a significant concern in human health.
In summary, an increasing trend of antibiotic resistance observed over the years. The emergence and increase of antimicrobial resistance are a constant threat and challenge to control infections in Malaysia. The epidemiological infections due to antimicrobialresistant bacteria have emerged in Malaysia. This study provides a scenario of recent antimicrobial uses all over Malaysia and this will be an aid to reduce acquisition of MDR. Limited infection control measures, lack of antimicrobial control, and travel throughout this region have likely contributed to the 
